|
- All articles from Drug Topics are reprinted with the permission
of Drug Topics, Medical Economics Co, April 2002.
- FDA Performance
Plan 2002: Reduce adverse events related to medical products.
This section of the Performance Plan describes FDA's strategies to reduce
preventable deaths and injuries associated with the use of medical
products.
-
Retrospective
analysis of mortalities associated with medication errors.
This American Journal of Health-System Pharmacy article by Jerry
Phillips, Associate Director, Office of Drug Safety, and others, discusses the types, causes, contributing
factors, and patient demographics of fatal medication errors. (The complete article can be downloaded
in Acrobat PDF format (requires an Acrobat
Reader, which is free).
- Food
and Drug Administration Science Background: Safety of Sodium Phosphates
Oral Solution. The Division of
Over-the-Counter Drug Products has posted a science backgrounder that
provides safety information to health care practitioners
concerning dosage warnings about the risks of sodium phosphate products.
- Final Summary of Food
and Drug Administration (FDA) Action Items - Doing What Counts for Patient Safety: Federal
Actions to Reduce Medical Errors and Their Impact.
- To Err is Human:
Building a Safer Health System. This 1999 report from the Institute
of Medicine describes a comprehensive approach to improving patient safety by designing
safety into the health care system.
- Managing the Risks from Medical
Product Use: Creating a Risk Management Framework. For every medical product
FDA approves, the Agency has to balance the benefits of the product against any risks it
may pose. This 1999 report to the FDA Commissioner from the Task Force on Risk
Management reviews the programs currently in place that help the agency make these
decisions.
- FDA Consumer Magazine,
September-October 2000. "Make No Mistake: Medical Errors can
be Deadly Serious."
- FDA Medical Bulletin,
"Medication Errors" (Summer 1997). This
article describes measures taken by FDA to avoid confusion with Brevibloc injection dosage
forms.
- Medication
Error Program. This 1999 slide presentation by Jerry Phillips, RPH, Associate
Director, Office of Drug Safety, explains how the Office plans to increase the safe use of drug products by minimizing
user error related to the labeling and/or packaging of the product.
- Proprietary Name
Review for Unithroid. Summary of medication errors with levothyroxine.
-
Patient Safety Resource Center Information from the American
Society of Health-System Pharmacists (ASHP)
- The National Coordinating Council for
Medication Error Reporting and Prevention
PDF requires the free Adobe
Acrobat Reader
Back to Top
Back to
Medication Errors
FDA/Center for Drug Evaluation and Research
Last Updated: April 21, 2006
Originator: OTCOM/DLIS
HTML by SJW |